Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone therapy in the WHI era.

Henry G Burger1

  • 1Prince Henry's Institute of Medical Research and Jean Hailes Foundation for Women's Health, Clayton, Victoria, Australia. henry.burger@princehenrys.org

The Australian & New Zealand Journal of Obstetrics & Gynaecology
|April 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations.

The Medical journal of Australia·2016
Same author

Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy.

The Medical journal of Australia·2016
Same author

Competency in menopause management: whither goest the internist?

Journal of women's health (2002)·2014
Same author

Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.

Journal of the National Cancer Institute·2013
Same author

The perimenopausal woman: endocrinology and management.

The Journal of steroid biochemistry and molecular biology·2013
Same author

Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings: authors' response.

The journal of family planning and reproductive health care·2013
Same journal

Determining the Feasibility of a No-Ultrasound Screening Tool for Early Medical Abortion in Australia.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

'All In': Equitable Health Outcomes Require Culturally Safe Care for Everybody.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Benzylpenicillin Concentrations in Intrapartum Group B Streptococcus Prevention Guidelines; A Systematic Review of the Evidence.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Retrospective Cohort Study of Foetal Growth Restricted Births After 40 Weeks at an Australian Tertiary Maternity Hospital Between 2018 and 2021.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Models of Antenatal Care for Rural Indigenous Women: A Systematic Review.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Dispensing of Antiemetics During Pregnancy in Aotearoa New Zealand, 2005-2020.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
See all related articles

The Women's Health Initiative (WHI) study results did not support widespread fear of hormone therapy. Established guidelines for menopausal hormone therapy remain valid, as the WHI trial focused on chronic disease prevention.

Area of Science:

  • Reproductive Medicine
  • Clinical Trials
  • Public Health

Background:

  • Media announcement of Women's Health Initiative (WHI) results in 2002 significantly impacted public and professional views on hormone therapy.
  • Widespread fear generated by the WHI announcement appears disproportionate to the actual findings.

Purpose of the Study:

  • To critically evaluate the WHI announcement and its implications for menopausal hormone therapy.
  • To assess whether the WHI results warranted changes to existing hormone therapy guidelines.

Main Methods:

  • Analysis of the combined continuous hormone treatment arm of the Women's Health Initiative (WHI).
  • Interpretation of the WHI trial's design, which focused on chronic disease prevention, not solely menopausal hormone therapy efficacy.

Related Experiment Videos

  • Comparison of WHI findings with existing data on hormone therapy.

    • Main Results:

    • The WHI trial was not designed as a randomized controlled trial for menopausal hormone therapy efficacy.
    • The trial primarily investigated chronic disease prevention, specifically cardiovascular benefits of combination hormone therapy.
    • WHI results were consistent with prior data and did not necessitate changes to established hormone therapy guidelines.

    Conclusions:

    • The fear surrounding hormone therapy post-WHI announcement was not factually supported.
    • Existing guidelines for menopausal hormone therapy use remain appropriate.
    • Tibolone presents an alternative for menopausal symptoms, but its long-term safety and efficacy require further investigation.